BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Pharm-Olam International Ltd. Ranked Sixth Among 300,000 Companies in Ukraine


8/17/2010 10:55:55 AM

HOUSTON, TEXAS August 17, 2010. Pharm-Olam International Ltd. and MB Quest LLC, a member of the Pharm-Olam International Group, a multi-national full service CRO to pharmaceutical and biotech industries announce that MBQ Ukraine was published in the Ukrainian Chamber of Commerce and Industry Catalogue as ranked sixth among 300,000 companies.

The ranking was based on 2009 financial statements submitted to Ukraine statistical authorities which placed MB Quest - Ukraine to be among 10 best Ukrainian companies in main activity category under the Foreign Economic Activity Classifier including companies such as Microsoft and Samsung.

The ranking studied more than 300,000 companies in all sectors of Ukrainian economy using four appraisal criteria including volume of sales, net profit, labor productivity and wage level.

"We have very talented staff in Ukraine to receive such recognition. Data from our studies there has supported successful US NDA approval in infectious disease and urology”, said Eugene Barg, President of MB Quest. “I am proud of our accomplishments in clinical research and business in Ukraine.“

The Pharm-Olam International Group has 27 offices worldwide to assist sponsors in Phase I to Phase IV research. MB Quest which operates in Russia, Ukraine, Georgia, Belarus, and Kazakhstan is a member of the Pharm-Olam International Group.

For further information about conducting trials with Pharm-Olam please contact John Hovre, COO at john.hovre@pharm-olam.com

About Pharm-Olam International Group

Pharm-Olam International is a multi-national contract research organization offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, POI focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. Pharm-Olam International Group is organized with operations managed in three Groups – North & South America with headquarters in Houston, Texas, UK & European with headquarters in London, England, and Russia/Ukraine with headquarters in Moscow, Russia.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES